Eunus S. Ali

Postdoc, Northwestern University
Lloyd Mabonga

Postdoctoral Research Scientist, University of Pretoria, Pan African Cancer Research Institute (PACRI)

Subham Preetam

Early Stage Researcher (R1), DGIST

Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals. With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer. 
Bernard Ademola

Student, University of Benin

Hasan Mamar

PhD student, Biological Research Center/ University of Szeged

Özgün Özalp

Postdoctoral Fellow , University of Zurich

Christian Frezza

Professor of metabolomics in ageing, CECAD, University of Cologne

Our lab uses genetically modified mouse models and a combination of cell biology, molecular biology, and biochemistry techniques to study the role of altered mitochondrial dysfunction and metabolism in human diseases. A primary analytical tool of the group is metabolomics, which enables the parallel quantification of hundreds of small molecule metabolites. The team also uses computational approaches to integrate datasets from multi-dimensional analyses, including metabolomics, proteomics, and transcriptomics, with the aim to model aging-related disorders and to generate mechanistic hypotheses that will be cross validated experimentally.